Cargando…
Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors
Neuroendocrine tumors are a rare and heterogeneous group of tumors with a variety of primary origins and variable aggressiveness. Platinum-based chemotherapy has been the cornerstone of treatment for the poorly differentiated tumors. However, well-differentiated neuroendocrine tumors are quite chemo...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755420/ https://www.ncbi.nlm.nih.gov/pubmed/26929640 http://dx.doi.org/10.2147/OTT.S72155 |